Global Sustained Release Injectables Market Research Report 2024

Report ID: 1891309 | Published Date: Oct 2024 | No. of Page: 109 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Sustained Release Injectables Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Microparticles
        1.2.3 Implants
        1.2.4 Gels
    1.3 Market by Application
        1.3.1 Global Sustained Release Injectables Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Diabetes
        1.3.3 Leukemia
        1.3.4 Acromegaly
        1.3.5 Ophthalmology
        1.3.6 CNS
        1.3.7 Rheumatology
        1.3.8 Oncology
        1.3.9 Reproductive Health
        1.3.10 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Sustained Release Injectables Market Perspective (2017-2028)
    2.2 Sustained Release Injectables Growth Trends by Region
        2.2.1 Sustained Release Injectables Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Sustained Release Injectables Historic Market Size by Region (2017-2022)
        2.2.3 Sustained Release Injectables Forecasted Market Size by Region (2023-2028)
    2.3 Sustained Release Injectables Market Dynamics
        2.3.1 Sustained Release Injectables Industry Trends
        2.3.2 Sustained Release Injectables Market Drivers
        2.3.3 Sustained Release Injectables Market Challenges
        2.3.4 Sustained Release Injectables Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Sustained Release Injectables Players by Revenue
        3.1.1 Global Top Sustained Release Injectables Players by Revenue (2017-2022)
        3.1.2 Global Sustained Release Injectables Revenue Market Share by Players (2017-2022)
    3.2 Global Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Sustained Release Injectables Revenue
    3.4 Global Sustained Release Injectables Market Concentration Ratio
        3.4.1 Global Sustained Release Injectables Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Sustained Release Injectables Revenue in 2021
    3.5 Sustained Release Injectables Key Players Head office and Area Served
    3.6 Key Players Sustained Release Injectables Product Solution and Service
    3.7 Date of Enter into Sustained Release Injectables Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Sustained Release Injectables Breakdown Data by Type
    4.1 Global Sustained Release Injectables Historic Market Size by Type (2017-2022)
    4.2 Global Sustained Release Injectables Forecasted Market Size by Type (2023-2028)
5 Sustained Release Injectables Breakdown Data by Application
    5.1 Global Sustained Release Injectables Historic Market Size by Application (2017-2022)
    5.2 Global Sustained Release Injectables Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Sustained Release Injectables Market Size (2017-2028)
    6.2 North America Sustained Release Injectables Market Size by Country (2017-2022)
    6.3 North America Sustained Release Injectables Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Sustained Release Injectables Market Size (2017-2028)
    7.2 Europe Sustained Release Injectables Market Size by Country (2017-2022)
    7.3 Europe Sustained Release Injectables Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Sustained Release Injectables Market Size (2017-2028)
    8.2 Asia-Pacific Sustained Release Injectables Market Size by Country (2017-2022)
    8.3 Asia-Pacific Sustained Release Injectables Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Sustained Release Injectables Market Size (2017-2028)
    9.2 Latin America Sustained Release Injectables Market Size by Country (2017-2022)
    9.3 Latin America Sustained Release Injectables Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Sustained Release Injectables Market Size (2017-2028)
    10.2 Middle East & Africa Sustained Release Injectables Market Size by Country (2017-2022)
    10.3 Middle East & Africa Sustained Release Injectables Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 AntriaBio
        11.1.1 AntriaBio Company Detail
        11.1.2 AntriaBio Business Overview
        11.1.3 AntriaBio Sustained Release Injectables Introduction
        11.1.4 AntriaBio Revenue in Sustained Release Injectables Business (2017-2022)
        11.1.5 AntriaBio Recent Development
    11.2 Ascendis Pharma
        11.2.1 Ascendis Pharma Company Detail
        11.2.2 Ascendis Pharma Business Overview
        11.2.3 Ascendis Pharma Sustained Release Injectables Introduction
        11.2.4 Ascendis Pharma Revenue in Sustained Release Injectables Business (2017-2022)
        11.2.5 Ascendis Pharma Recent Development
    11.3 AstraZeneca
        11.3.1 AstraZeneca Company Detail
        11.3.2 AstraZeneca Business Overview
        11.3.3 AstraZeneca Sustained Release Injectables Introduction
        11.3.4 AstraZeneca Revenue in Sustained Release Injectables Business (2017-2022)
        11.3.5 AstraZeneca Recent Development
    11.4 Aurobindo
        11.4.1 Aurobindo Company Detail
        11.4.2 Aurobindo Business Overview
        11.4.3 Aurobindo Sustained Release Injectables Introduction
        11.4.4 Aurobindo Revenue in Sustained Release Injectables Business (2017-2022)
        11.4.5 Aurobindo Recent Development
    11.5 Avadel
        11.5.1 Avadel Company Detail
        11.5.2 Avadel Business Overview
        11.5.3 Avadel Sustained Release Injectables Introduction
        11.5.4 Avadel Revenue in Sustained Release Injectables Business (2017-2022)
        11.5.5 Avadel Recent Development
    11.6 Alkermes
        11.6.1 Alkermes Company Detail
        11.6.2 Alkermes Business Overview
        11.6.3 Alkermes Sustained Release Injectables Introduction
        11.6.4 Alkermes Revenue in Sustained Release Injectables Business (2017-2022)
        11.6.5 Alkermes Recent Development
    11.7 Amylin Pharmaceuticals
        11.7.1 Amylin Pharmaceuticals Company Detail
        11.7.2 Amylin Pharmaceuticals Business Overview
        11.7.3 Amylin Pharmaceuticals Sustained Release Injectables Introduction
        11.7.4 Amylin Pharmaceuticals Revenue in Sustained Release Injectables Business (2017-2022)
        11.7.5 Amylin Pharmaceuticals Recent Development
    11.8 Biomarin
        11.8.1 Biomarin Company Detail
        11.8.2 Biomarin Business Overview
        11.8.3 Biomarin Sustained Release Injectables Introduction
        11.8.4 Biomarin Revenue in Sustained Release Injectables Business (2017-2022)
        11.8.5 Biomarin Recent Development
    11.9 Camurus
        11.9.1 Camurus Company Detail
        11.9.2 Camurus Business Overview
        11.9.3 Camurus Sustained Release Injectables Introduction
        11.9.4 Camurus Revenue in Sustained Release Injectables Business (2017-2022)
        11.9.5 Camurus Recent Development
    11.10 Critical Pharmaceuticals
        11.10.1 Critical Pharmaceuticals Company Detail
        11.10.2 Critical Pharmaceuticals Business Overview
        11.10.3 Critical Pharmaceuticals Sustained Release Injectables Introduction
        11.10.4 Critical Pharmaceuticals Revenue in Sustained Release Injectables Business (2017-2022)
        11.10.5 Critical Pharmaceuticals Recent Development
    11.11 Durect
        11.11.1 Durect Company Detail
        11.11.2 Durect Business Overview
        11.11.3 Durect Sustained Release Injectables Introduction
        11.11.4 Durect Revenue in Sustained Release Injectables Business (2017-2022)
        11.11.5 Durect Recent Development
    11.12 Eli Lilly
        11.12.1 Eli Lilly Company Detail
        11.12.2 Eli Lilly Business Overview
        11.12.3 Eli Lilly Sustained Release Injectables Introduction
        11.12.4 Eli Lilly Revenue in Sustained Release Injectables Business (2017-2022)
        11.12.5 Eli Lilly Recent Development
    11.13 Enzon
        11.13.1 Enzon Company Detail
        11.13.2 Enzon Business Overview
        11.13.3 Enzon Sustained Release Injectables Introduction
        11.13.4 Enzon Revenue in Sustained Release Injectables Business (2017-2022)
        11.13.5 Enzon Recent Development
    11.14 Ipsen
        11.14.1 Ipsen Company Detail
        11.14.2 Ipsen Business Overview
        11.14.3 Ipsen Sustained Release Injectables Introduction
        11.14.4 Ipsen Revenue in Sustained Release Injectables Business (2017-2022)
        11.14.5 Ipsen Recent Development
    11.15 InnoCore Pharmaceuticals
        11.15.1 InnoCore Pharmaceuticals Company Detail
        11.15.2 InnoCore Pharmaceuticals Business Overview
        11.15.3 InnoCore Pharmaceuticals Sustained Release Injectables Introduction
        11.15.4 InnoCore Pharmaceuticals Revenue in Sustained Release Injectables Business (2017-2022)
        11.15.5 InnoCore Pharmaceuticals Recent Development
    11.16 Janssen
        11.16.1 Janssen Company Detail
        11.16.2 Janssen Business Overview
        11.16.3 Janssen Sustained Release Injectables Introduction
        11.16.4 Janssen Revenue in Sustained Release Injectables Business (2017-2022)
        11.16.5 Janssen Recent Development
    11.17 Merck
        11.17.1 Merck Company Detail
        11.17.2 Merck Business Overview
        11.17.3 Merck Sustained Release Injectables Introduction
        11.17.4 Merck Revenue in Sustained Release Injectables Business (2017-2022)
        11.17.5 Merck Recent Development
    11.18 NanOlogy
        11.18.1 NanOlogy Company Detail
        11.18.2 NanOlogy Business Overview
        11.18.3 NanOlogy Sustained Release Injectables Introduction
        11.18.4 NanOlogy Revenue in Sustained Release Injectables Business (2017-2022)
        11.18.5 NanOlogy Recent Development
    11.19 Novartis
        11.19.1 Novartis Company Detail
        11.19.2 Novartis Business Overview
        11.19.3 Novartis Sustained Release Injectables Introduction
        11.19.4 Novartis Revenue in Sustained Release Injectables Business (2017-2022)
        11.19.5 Novartis Recent Development
    11.20 Oakwood Laboratories/PharmaSophia
        11.20.1 Oakwood Laboratories/PharmaSophia Company Detail
        11.20.2 Oakwood Laboratories/PharmaSophia Business Overview
        11.20.3 Oakwood Laboratories/PharmaSophia Sustained Release Injectables Introduction
        11.20.4 Oakwood Laboratories/PharmaSophia Revenue in Sustained Release Injectables Business (2017-2022)
        11.20.5 Oakwood Laboratories/PharmaSophia Recent Development
    11.21 OctoPlus
        11.21.1 OctoPlus Company Detail
        11.21.2 OctoPlus Business Overview
        11.21.3 OctoPlus Sustained Release Injectables Introduction
        11.21.4 OctoPlus Revenue in Sustained Release Injectables Business (2017-2022)
        11.21.5 OctoPlus Recent Development
    11.22 Pacira
        11.22.1 Pacira Company Detail
        11.22.2 Pacira Business Overview
        11.22.3 Pacira Sustained Release Injectables Introduction
        11.22.4 Pacira Revenue in Sustained Release Injectables Business (2017-2022)
        11.22.5 Pacira Recent Development
    11.23 PhaseBio Pharmaceuticals
        11.23.1 PhaseBio Pharmaceuticals Company Detail
        11.23.2 PhaseBio Pharmaceuticals Business Overview
        11.23.3 PhaseBio Pharmaceuticals Sustained Release Injectables Introduction
        11.23.4 PhaseBio Pharmaceuticals Revenue in Sustained Release Injectables Business (2017-2022)
        11.23.5 PhaseBio Pharmaceuticals Recent Development
    11.24 Recipharm AB
        11.24.1 Recipharm AB Company Detail
        11.24.2 Recipharm AB Business Overview
        11.24.3 Recipharm AB Sustained Release Injectables Introduction
        11.24.4 Recipharm AB Revenue in Sustained Release Injectables Business (2017-2022)
        11.24.5 Recipharm AB Recent Development
    11.25 Roche
        11.25.1 Roche Company Detail
        11.25.2 Roche Business Overview
        11.25.3 Roche Sustained Release Injectables Introduction
        11.25.4 Roche Revenue in Sustained Release Injectables Business (2017-2022)
        11.25.5 Roche Recent Development
    11.26 Sanofi
        11.26.1 Sanofi Company Detail
        11.26.2 Sanofi Business Overview
        11.26.3 Sanofi Sustained Release Injectables Introduction
        11.26.4 Sanofi Revenue in Sustained Release Injectables Business (2017-2022)
        11.26.5 Sanofi Recent Development
    11.27 Taiwan Liposome Company (TLC)
        11.27.1 Taiwan Liposome Company (TLC) Company Detail
        11.27.2 Taiwan Liposome Company (TLC) Business Overview
        11.27.3 Taiwan Liposome Company (TLC) Sustained Release Injectables Introduction
        11.27.4 Taiwan Liposome Company (TLC) Revenue in Sustained Release Injectables Business (2017-2022)
        11.27.5 Taiwan Liposome Company (TLC) Recent Development
    11.28 Xbrane Biopharma
        11.28.1 Xbrane Biopharma Company Detail
        11.28.2 Xbrane Biopharma Business Overview
        11.28.3 Xbrane Biopharma Sustained Release Injectables Introduction
        11.28.4 Xbrane Biopharma Revenue in Sustained Release Injectables Business (2017-2022)
        11.28.5 Xbrane Biopharma Recent Development
    11.29 Livzon Pharm
        11.29.1 Livzon Pharm Company Detail
        11.29.2 Livzon Pharm Business Overview
        11.29.3 Livzon Pharm Sustained Release Injectables Introduction
        11.29.4 Livzon Pharm Revenue in Sustained Release Injectables Business (2017-2022)
        11.29.5 Livzon Pharm Recent Development
    11.30 Luye Pharma Group
        11.30.1 Luye Pharma Group Company Detail
        11.30.2 Luye Pharma Group Business Overview
        11.30.3 Luye Pharma Group Sustained Release Injectables Introduction
        11.30.4 Luye Pharma Group Revenue in Sustained Release Injectables Business (2017-2022)
        11.30.5 Luye Pharma Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Sustained Release Injectables Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Microparticles
    Table 3. Key Players of Implants
    Table 4. Key Players of Gels
    Table 5. Global Sustained Release Injectables Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Sustained Release Injectables Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Sustained Release Injectables Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Sustained Release Injectables Market Share by Region (2017-2022)
    Table 9. Global Sustained Release Injectables Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Sustained Release Injectables Market Share by Region (2023-2028)
    Table 11. Sustained Release Injectables Market Trends
    Table 12. Sustained Release Injectables Market Drivers
    Table 13. Sustained Release Injectables Market Challenges
    Table 14. Sustained Release Injectables Market Restraints
    Table 15. Global Sustained Release Injectables Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Sustained Release Injectables Market Share by Players (2017-2022)
    Table 17. Global Top Sustained Release Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained Release Injectables as of 2021)
    Table 18. Ranking of Global Top Sustained Release Injectables Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Sustained Release Injectables Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Sustained Release Injectables Product Solution and Service
    Table 22. Date of Enter into Sustained Release Injectables Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Sustained Release Injectables Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Sustained Release Injectables Revenue Market Share by Type (2017-2022)
    Table 26. Global Sustained Release Injectables Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Sustained Release Injectables Revenue Market Share by Type (2023-2028)
    Table 28. Global Sustained Release Injectables Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Sustained Release Injectables Revenue Market Share by Application (2017-2022)
    Table 30. Global Sustained Release Injectables Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Sustained Release Injectables Revenue Market Share by Application (2023-2028)
    Table 32. North America Sustained Release Injectables Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Sustained Release Injectables Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Sustained Release Injectables Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Sustained Release Injectables Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Sustained Release Injectables Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Sustained Release Injectables Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Sustained Release Injectables Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Sustained Release Injectables Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Sustained Release Injectables Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Sustained Release Injectables Market Size by Country (2023-2028) & (US$ Million)
    Table 42. AntriaBio Company Detail
    Table 43. AntriaBio Business Overview
    Table 44. AntriaBio Sustained Release Injectables Product
    Table 45. AntriaBio Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 46. AntriaBio Recent Development
    Table 47. Ascendis Pharma Company Detail
    Table 48. Ascendis Pharma Business Overview
    Table 49. Ascendis Pharma Sustained Release Injectables Product
    Table 50. Ascendis Pharma Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 51. Ascendis Pharma Recent Development
    Table 52. AstraZeneca Company Detail
    Table 53. AstraZeneca Business Overview
    Table 54. AstraZeneca Sustained Release Injectables Product
    Table 55. AstraZeneca Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 56. AstraZeneca Recent Development
    Table 57. Aurobindo Company Detail
    Table 58. Aurobindo Business Overview
    Table 59. Aurobindo Sustained Release Injectables Product
    Table 60. Aurobindo Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 61. Aurobindo Recent Development
    Table 62. Avadel Company Detail
    Table 63. Avadel Business Overview
    Table 64. Avadel Sustained Release Injectables Product
    Table 65. Avadel Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 66. Avadel Recent Development
    Table 67. Alkermes Company Detail
    Table 68. Alkermes Business Overview
    Table 69. Alkermes Sustained Release Injectables Product
    Table 70. Alkermes Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 71. Alkermes Recent Development
    Table 72. Amylin Pharmaceuticals Company Detail
    Table 73. Amylin Pharmaceuticals Business Overview
    Table 74. Amylin Pharmaceuticals Sustained Release Injectables Product
    Table 75. Amylin Pharmaceuticals Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 76. Amylin Pharmaceuticals Recent Development
    Table 77. Biomarin Company Detail
    Table 78. Biomarin Business Overview
    Table 79. Biomarin Sustained Release Injectables Product
    Table 80. Biomarin Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 81. Biomarin Recent Development
    Table 82. Camurus Company Detail
    Table 83. Camurus Business Overview
    Table 84. Camurus Sustained Release Injectables Product
    Table 85. Camurus Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 86. Camurus Recent Development
    Table 87. Critical Pharmaceuticals Company Detail
    Table 88. Critical Pharmaceuticals Business Overview
    Table 89. Critical Pharmaceuticals Sustained Release Injectables Product
    Table 90. Critical Pharmaceuticals Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 91. Critical Pharmaceuticals Recent Development
    Table 92. Durect Company Detail
    Table 93. Durect Business Overview
    Table 94. Durect Sustained Release InjectablesProduct
    Table 95. Durect Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 96. Durect Recent Development
    Table 97. Eli Lilly Company Detail
    Table 98. Eli Lilly Business Overview
    Table 99. Eli Lilly Sustained Release InjectablesProduct
    Table 100. Eli Lilly Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 101. Eli Lilly Recent Development
    Table 102. Enzon Company Detail
    Table 103. Enzon Business Overview
    Table 104. Enzon Sustained Release InjectablesProduct
    Table 105. Enzon Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 106. Enzon Recent Development
    Table 107. Ipsen Company Detail
    Table 108. Ipsen Business Overview
    Table 109. Ipsen Sustained Release InjectablesProduct
    Table 110. Ipsen Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 111. Ipsen Recent Development
    Table 112. InnoCore Pharmaceuticals Company Detail
    Table 113. InnoCore Pharmaceuticals Business Overview
    Table 114. InnoCore Pharmaceuticals Sustained Release InjectablesProduct
    Table 115. InnoCore Pharmaceuticals Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 116. InnoCore Pharmaceuticals Recent Development
    Table 117. Janssen Company Detail
    Table 118. Janssen Business Overview
    Table 119. Janssen Sustained Release InjectablesProduct
    Table 120. Janssen Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 121. Janssen Recent Development
    Table 122. Merck Company Detail
    Table 123. Merck Business Overview
    Table 124. Merck Sustained Release InjectablesProduct
    Table 125. Merck Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 126. Merck Recent Development
    Table 127. NanOlogy Company Detail
    Table 128. NanOlogy Business Overview
    Table 129. NanOlogy Sustained Release InjectablesProduct
    Table 130. NanOlogy Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 131. NanOlogy Recent Development
    Table 132. Novartis Company Detail
    Table 133. Novartis Business Overview
    Table 134. Novartis Sustained Release InjectablesProduct
    Table 135. Novartis Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 136. Novartis Recent Development
    Table 137. Oakwood Laboratories/PharmaSophia Company Detail
    Table 138. Oakwood Laboratories/PharmaSophia Business Overview
    Table 139. Oakwood Laboratories/PharmaSophia Sustained Release InjectablesProduct
    Table 140. Oakwood Laboratories/PharmaSophia Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 141. Oakwood Laboratories/PharmaSophia Recent Development
    Table 142. OctoPlus Company Detail
    Table 143. OctoPlus Business Overview
    Table 144. OctoPlus Sustained Release InjectablesProduct
    Table 145. OctoPlus Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 146. OctoPlus Recent Development
    Table 147. Pacira Company Detail
    Table 148. Pacira Business Overview
    Table 149. Pacira Sustained Release InjectablesProduct
    Table 150. Pacira Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 151. Pacira Recent Development
    Table 152. PhaseBio Pharmaceuticals Company Detail
    Table 153. PhaseBio Pharmaceuticals Business Overview
    Table 154. PhaseBio Pharmaceuticals Sustained Release InjectablesProduct
    Table 155. PhaseBio Pharmaceuticals Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 156. PhaseBio Pharmaceuticals Recent Development
    Table 157. Recipharm AB Company Detail
    Table 158. Recipharm AB Business Overview
    Table 159. Recipharm AB Sustained Release InjectablesProduct
    Table 160. Recipharm AB Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 161. Recipharm AB Recent Development
    Table 162. Roche Company Detail
    Table 163. Roche Business Overview
    Table 164. Roche Sustained Release InjectablesProduct
    Table 165. Roche Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 166. Roche Recent Development
    Table 167. Sanofi Company Detail
    Table 168. Sanofi Business Overview
    Table 169. Sanofi Sustained Release InjectablesProduct
    Table 170. Sanofi Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 171. Sanofi Recent Development
    Table 172. Taiwan Liposome Company (TLC) Company Detail
    Table 173. Taiwan Liposome Company (TLC) Business Overview
    Table 174. Taiwan Liposome Company (TLC) Sustained Release InjectablesProduct
    Table 175. Taiwan Liposome Company (TLC) Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 176. Taiwan Liposome Company (TLC) Recent Development
    Table 177. Xbrane Biopharma Company Detail
    Table 178. Xbrane Biopharma Business Overview
    Table 179. Xbrane Biopharma Sustained Release InjectablesProduct
    Table 180. Xbrane Biopharma Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 181. Xbrane Biopharma Recent Development
    Table 182. Livzon Pharm Company Detail
    Table 183. Livzon Pharm Business Overview
    Table 184. Livzon Pharm Sustained Release InjectablesProduct
    Table 185. Livzon Pharm Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 186. Livzon Pharm Recent Development
    Table 187. Luye Pharma Group Company Detail
    Table 188. Luye Pharma Group Business Overview
    Table 189. Luye Pharma Group Sustained Release InjectablesProduct
    Table 190. Luye Pharma Group Revenue in Sustained Release Injectables Business (2017-2022) & (US$ Million)
    Table 191. Luye Pharma Group Recent Development
    Table 192. Research Programs/Design for This Report
    Table 193. Key Data Information from Secondary Sources
    Table 194. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sustained Release Injectables Market Share by Type: 2021 VS 2028
    Figure 2. Microparticles Features
    Figure 3. Implants Features
    Figure 4. Gels Features
    Figure 5. Global Sustained Release Injectables Market Share by Application in 2021 & 2028
    Figure 6. Diabetes Case Studies
    Figure 7. Leukemia Case Studies
    Figure 8. Acromegaly Case Studies
    Figure 9. Ophthalmology Case Studies
    Figure 10. CNS Case Studies
    Figure 11. Rheumatology Case Studies
    Figure 12. Oncology Case Studies
    Figure 13. Reproductive Health Case Studies
    Figure 14. Others Case Studies
    Figure 15. Sustained Release Injectables Report Years Considered
    Figure 16. Global Sustained Release Injectables Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 17. Global Sustained Release Injectables Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Sustained Release Injectables Market Share by Region: 2021 VS 2028
    Figure 19. Global Sustained Release Injectables Market Share by Players in 2021
    Figure 20. Global Top Sustained Release Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained Release Injectables as of 2021)
    Figure 21. The Top 10 and 5 Players Market Share by Sustained Release Injectables Revenue in 2021
    Figure 22. North America Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. North America Sustained Release Injectables Market Share by Country (2017-2028)
    Figure 24. United States Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe Sustained Release Injectables Market Share by Country (2017-2028)
    Figure 28. Germany Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Sustained Release Injectables Market Share by Region (2017-2028)
    Figure 36. China Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Latin America Sustained Release Injectables Market Share by Country (2017-2028)
    Figure 44. Mexico Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Brazil Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Sustained Release Injectables Market Share by Country (2017-2028)
    Figure 48. Turkey Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Saudi Arabia Sustained Release Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. AntriaBio Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 51. Ascendis Pharma Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 52. AstraZeneca Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 53. Aurobindo Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 54. Avadel Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 55. Alkermes Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 56. Amylin Pharmaceuticals Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 57. Biomarin Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 58. Camurus Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 59. Critical Pharmaceuticals Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 60. Durect Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 61. Eli Lilly Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 62. Enzon Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 63. Ipsen Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 64. InnoCore Pharmaceuticals Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 65. Janssen Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 66. Merck Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 67. NanOlogy Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 68. Novartis Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 69. Oakwood Laboratories/PharmaSophia Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 70. OctoPlus Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 71. Pacira Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 72. PhaseBio Pharmaceuticals Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 73. Recipharm AB Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 74. Roche Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 75. Sanofi Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 76. Taiwan Liposome Company (TLC) Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 77. Xbrane Biopharma Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 78. Livzon Pharm Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 79. Luye Pharma Group Revenue Growth Rate in Sustained Release Injectables Business (2017-2022)
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AntriaBio
Ascendis Pharma
AstraZeneca
Aurobindo
Avadel
Alkermes
Amylin Pharmaceuticals
Biomarin
Camurus
Critical Pharmaceuticals
Durect
Eli Lilly
Enzon
Ipsen
InnoCore Pharmaceuticals
Janssen
Merck
NanOlogy
Novartis
Oakwood Laboratories/PharmaSophia
OctoPlus
Pacira
PhaseBio Pharmaceuticals
Recipharm AB
Roche
Sanofi
Taiwan Liposome Company (TLC)
Xbrane Biopharma
Livzon Pharm
Luye Pharma Group
Frequently Asked Questions
Sustained Release Injectables report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Sustained Release Injectables report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Sustained Release Injectables report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cosmetic Colorants

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Medical Mixture

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More